Akanksha Anjaneya

Akanksha Anjaneya

Active Director Director DIN 09568473
DIN 09568473 First appointment Apr 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Akanksha Anjaneya

Data last updated:

Akanksha Anjaneya is a Director at Lifin Health Sciences Private Limited (since 2023) and Director at Allypth Pharmaceuticals Private Limited (since 2022). The companies operate in Chemicals.

DIN 09568473
Primary Designation Director
Industry Chemicals
First Appointment 11 Apr 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jan 20232023Active
Director11 Apr 20222022Active

Board colleagues of Akanksha Anjaneya

Directorship timeline

Open interactive timeline →
Allypth Pharmaceuticals Private Limited
Lifin Health Sciences Private Limited
Premium access

Shareholding and investment profile for Akanksha Anjaneya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akanksha Anjaneya

Akanksha Anjaneya currently holds 2 directorships: Lifin Health Sciences Private Limited (Director, since 04 Jan 2023); Allypth Pharmaceuticals Private Limited (Director, since 11 Apr 2022).

Akanksha Anjaneya was first appointed on 11 Apr 2022 as Director at Allypth Pharmaceuticals Private Limited. The most recent appointment on record is 04 Jan 2023 at Lifin Health Sciences Private Limited.

The current boards of Akanksha Anjaneya's companies include Ghanshyam Kumar (Lifin Health Sciences Private Limited), Pratyush Prasad (Allypth Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available